Kataoka H, Itoh H, Seguchi K, Koono M
Second Department of Pathology, Miyazaki Medical College, Japan.
Acta Pathol Jpn. 1993 Oct;43(10):566-73. doi: 10.1111/j.1440-1827.1993.tb03232.x.
A new human cell line, LC-2/ad was established from pleural effusion of pulmonary adenocarcinoma of a 51 year old Japanese female. The LC-2/ad cells exhibit an epithelial appearance and a tendency to form small domes as observed with phase-contrast microscopy. The modal chromosome number was 53-56. Plating efficiency and doubling time were 6.8% and 58 h, respectively (32th passage). Immunocytochemically, the cells were strongly positive for CEA and cytokeratins including cytokeratin no. 18 which is present in simple epithelia. Ultrastructurally, the cultured cells were characterized by well-formed junctional complexes and microvilli. Subcutaneous injection of 5 x 10(6) cells into a nude mouse resulted in tumor formation classified histologically as a moderately differentiated adenocarcinoma. This cell line produced at least two functionally active trypsin inhibitors together with several proteinases in vitro. The main inhibitor was purified partially from the serum-free conditioned medium and confirmed immunologically as human alpha 1-antitrypsin (AAT). Immunohistochemically, the xenografted tumor was also positive for AAT. The cell line LC-2/ad is useful for the study of tumor-derived serine proteinase inhibitors, in particular AAT.
一株新的人细胞系LC-2/ad是从一名51岁日本女性肺腺癌胸腔积液中建立的。用相差显微镜观察发现,LC-2/ad细胞呈现上皮样外观,并有形成小穹顶的趋势。众数染色体数为53 - 56。接种效率和倍增时间分别为6.8%和58小时(第32代)。免疫细胞化学检测显示,这些细胞对癌胚抗原(CEA)和细胞角蛋白呈强阳性,包括存在于单层上皮中的细胞角蛋白18。超微结构上,培养的细胞以结构良好的连接复合体和微绒毛为特征。将5×10⁶个细胞皮下注射到裸鼠体内可导致肿瘤形成,组织学分类为中分化腺癌。该细胞系在体外产生至少两种具有功能活性的胰蛋白酶抑制剂以及几种蛋白酶。主要抑制剂从无血清条件培养基中部分纯化,并经免疫学鉴定为人α1-抗胰蛋白酶(AAT)。免疫组织化学检测显示,异种移植瘤对AAT也呈阳性。细胞系LC-2/ad可用于研究肿瘤来源的丝氨酸蛋白酶抑制剂,特别是AAT。